Clinical Trials Browser

Phase 4 × Has results × Lymphoma, Large B-Cell, Diffuse × Clear all

Lymphoma, Large B-Cell, Diffuse

NCT01990534 2021-04-09

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma